Evidence map›Paper›PMID 32993408›Full record

ArticleThe Journal of international medical research2020

Neuroprotective effect of apigenin against cerebral ischemia/reperfusion injury.

Chengli Ling, Chang Lei, Manshu Zou, Xiong Cai, Yun Xiang, Yu Xie, Xuran Li, Dan Huang, Yuhong Wang

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Food science & nutrition · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Role of Polyphenols as Antioxidant Supplementation in Ischemic Stroke.Oxidative medicine and cellular longevity · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chengli LingInstitute of Innovation and Applied Research in Chinese Medicine, Training Base of Province-Ministry Joint State Key Laboratory of Chinese Medicinal Powder and Innovative Medicinals, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.
Chang LeiInstitute of Innovation and Applied Research in Chinese Medicine, Training Base of Province-Ministry Joint State Key Laboratory of Chinese Medicinal Powder and Innovative Medicinals, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.
Manshu ZouInstitute of Innovation and Applied Research in Chinese Medicine, Training Base of Province-Ministry Joint State Key Laboratory of Chinese Medicinal Powder and Innovative Medicinals, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.
Xiong CaiInstitute of Innovation and Applied Research in Chinese Medicine, Training Base of Province-Ministry Joint State Key Laboratory of Chinese Medicinal Powder and Innovative Medicinals, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.
Yun XiangInstitute of Innovation and Applied Research in Chinese Medicine, Training Base of Province-Ministry Joint State Key Laboratory of Chinese Medicinal Powder and Innovative Medicinals, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.
Yu XieThe Second Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.
Xuran LiSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.
Dan HuangInstitute of Innovation and Applied Research in Chinese Medicine, Training Base of Province-Ministry Joint State Key Laboratory of Chinese Medicinal Powder and Innovative Medicinals, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.ORCID https://orcid.org/0000-0002-1411-2201
Yuhong WangInstitute of Innovation and Applied Research in Chinese Medicine, Training Base of Province-Ministry Joint State Key Laboratory of Chinese Medicinal Powder and Innovative Medicinals, Hunan University of Chinese Medicine, Changsha, Hunan, PR China.ORCID https://orcid.org/0000-0003-4221-574X
Hunan University of Traditional Chinese Medicine · CNSecond Affiliated Hospital of Hunan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe therapeutic efficacy of apigenin in PC12 cells and rats remains uncertain. The aim of this study was to investigate the neuroprotective effects of apigenin against cerebral ischemia/reperfusion injury, both

methodsWe first treated PC12 cells with cobalt chloride (CoCl

resultsThe half-inhibitory concentration of CoCl

conclusionsApigenin had excellent neuroprotective effects for the treatment of cerebral ischemia/reperfusion injury

Indexed as

Brain IschemiaNeuroprotective AgentsReperfusion InjuryAnimalsApigeninApoptosisInfarction, Middle Cerebral ArteryOxidative StressRatsApigeninNeuroprotective AgentsapigeninCerebral ischemia/reperfusionflavonoidsmiddle cerebral artery occlusion rat modelmitochondrianeuropharmacologyoxidative stressPC12 cell model

Identifiers

PMID32993408
PMCPMC7536502
OpenAlexW3090236314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.